Monitoring and tracking artificial intelligence development and risk assessment in real-time.

Skynet Chance (+0.01%): Expanding AI capabilities into biological systems and drug discovery increases the breadth of domains where advanced AI operates autonomously, marginally expanding potential surfaces for unintended consequences. However, healthcare AI typically operates under strict regulatory oversight, slightly mitigating risks.

Skynet Date (+0 days): The acquisition accelerates Anthropic's integration of AI into complex biological systems, potentially speeding up the development of more capable general-purpose AI systems. The impact on overall timeline is minimal as this represents domain expansion rather than core capability breakthrough.

AGI Progress (+0.01%): Applying AI to complex biological systems and drug discovery represents progress toward handling multi-domain reasoning and scientific discovery tasks, which are key components of general intelligence. The acquisition brings specialized expertise in computational biology that could inform broader AI development.

AGI Date (+0 days): The $400M investment and team acquisition demonstrate Anthropic's accelerated expansion into applied domains requiring sophisticated reasoning, potentially speeding up practical AGI development timelines. However, biotech applications alone don't fundamentally alter core AGI research pace.

Skynet Chance (+0.01%): The release of more capable multimodal models increases the general sophistication of AI systems in the market, but these are commercial tools with apparent human oversight and practical use focus rather than autonomous or agentic capabilities that would significantly heighten loss-of-control risks.

Skynet Date (+0 days): The models represent incremental capability advancement in multimodal AI, slightly accelerating the overall pace of AI sophistication deployment. However, the focus on practical commercial applications rather than autonomous systems limits the acceleration of existential risk timelines.

AGI Progress (+0.02%): The simultaneous deployment of text, voice, and video generation capabilities in foundational models demonstrates progress toward integrated multimodal AI systems, which is a component of AGI. However, these appear to be specialized models for narrow tasks rather than general-purpose reasoning systems.

AGI Date (+0 days): Microsoft's competitive push with cost-effective multimodal models accelerates market adoption and incentivizes faster development cycles across the industry. The formation of a dedicated "Superintelligence team" and rapid model releases suggest an accelerated timeline for advanced AI development.

Skynet Chance (+0.01%): Accelerating chip design could enable faster iteration of AI hardware, potentially making advanced AI systems more accessible and harder to control through hardware bottlenecks. However, this is primarily an efficiency improvement rather than a fundamental change in AI safety dynamics.

Skynet Date (-1 days): By cutting chip development timelines by more than half, this technology could accelerate the availability of more powerful AI hardware, potentially speeding the path to advanced AI systems. The reduction from 3-5 years to potentially 18-30 months for chip development represents a meaningful acceleration of the AI hardware supply chain.

AGI Progress (+0.02%): Faster and cheaper chip design directly enables more rapid iteration on AI hardware, which is a critical bottleneck for AGI development. The claimed 50%+ timeline reduction and 75%+ cost reduction could significantly accelerate the compute infrastructure needed for advanced AI systems.

AGI Date (-1 days): Reducing chip development time by over half could materially accelerate AGI timelines by removing a major infrastructure bottleneck. If specialized AI chips can be designed and deployed in 18-30 months instead of 3-5 years, the feedback loop between AI software advances and hardware optimization becomes much faster.